Fundies.
English

Bone Biologics Corporation

EDGAR
BBLG Quarterly report (10-Q) · filed 2026-10-26

117 filing records in this dataset, filed from 2008-05-15 to 2026-10-26. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

0 USD

2021-06-30 · USD

Exact inputs and evidence
  • Revenue: 1070000000 USD Source
  • Revenue: 1070000000 USD Source

Operating cash flow

-636 thousand USD

2021-06-30 · USD

Exact inputs and evidence
  • Operating Cash Flow: -763964 USD Source
  • Operating Cash Flow: -127983 USD Source
Cash and cash equivalents
6.19 million USD Source
Exact value

6188319 USD

Long-term debt including current maturities
Not available
Shares outstanding
3.39 million shares Source
Exact value

3389057 shares

Reported share-count change

88.78% · 1.59 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 1795260 shares · 2025-09-30· Source
  • 3389057 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.07 billion USD

2020-07-01 – 2021-06-30

Exact inputs and evidence
  • Revenue: 1070000000 USD · 2020-01-01 – 2020-09-30 Source
  • Revenue: 1070000000 USD · 2020-01-01 – 2020-06-30 Source
  • Revenue: 1070000000 USD · 2020-01-01 – 2020-12-31 Source
  • Revenue: 1070000000 USD · 2020-01-01 – 2020-09-30 Source
  • Revenue: 1070000000 USD · 2021-01-01 – 2021-03-31 Source
  • Revenue: 1070000000 USD · 2021-01-01 – 2021-06-30 Source
  • Revenue: 1070000000 USD · 2021-01-01 – 2021-03-31 Source

Net income

-2.84 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -3108991 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -2424348 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -765988 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -773702 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -617651 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-2.62 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -2700000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -1976388 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -800000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -1300000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -800000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -1900000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -1300000 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-26.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2020-12-31
  • Operating income: 11 of 11 periods available· newest 2025-12-31
  • Net income: 11 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 1 of 11 periods available· newest 2015-12-31
  • Total assets: 11 of 11 periods available· newest 2025-12-31
  • Total liabilities: 11 of 11 periods available· newest 2025-12-31
  • Current assets: 9 of 11 periods available· newest 2025-12-31
  • Current liabilities: 11 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 7 of 11 periods available· newest 2022-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +USD 1 million

    Prior period

    −USD 4.11 million

    –

    Current period

    −USD 3.11 million

    –

    Exact inputs and evidence

    -3108991 − -4112420 = 1003429 USD

    -4112420 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -3108991 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 1.42 million

    Prior period

    −USD 4.12 million

    –

    Current period

    −USD 2.7 million

    –

    Exact inputs and evidence

    -2700000 − -4124935 = 1424935 USD

    -4124935 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -2700000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2020-01-01 – 2020-12-31

  • Revenue USD 1.07 billion 100% of revenue
  • Operating costs Derived USD 1.07 billion 100% of revenue
  • Operating income −USD 825,014 −0.1% of revenue
  • Tax, interest and other Derived USD 999,676 0.1% of revenue
  • Net income −USD 1.82 million −0.2% of revenue

Cash

  • Operating cash flow −USD 426,933 −0% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2016 Operating loss: operating costs were 102% of revenue.
  • 2019 Operating loss: operating costs were 100% of revenue.
  • 2020 Operating loss: operating costs were 100% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2016 2016-01-01 – 2016-12-311070000000 1090412278 Derived -20412278 5466397 Derived -25878675 Unavailable
Source
2019 2019-01-01 – 2019-12-311070000000 1072447434 Derived -2447434 977377 Derived -3424811 Unavailable
Source
2020 2020-01-01 – 2020-12-311070000000 1070825014 Derived -825014 999676 Derived -1824690 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.1B 2020
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.2B866.7M577.8M288.9M0.0201620192020
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Revenue1070000000
2019Revenue1070000000
2020Revenue1070000000

Revenue growth

Change in revenue from the same financial period one year earlier.

0% 2020
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.08%0.81%0.54%0.27%0.00%201620192020
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2016Year over yearNo prior comparable period
2019Year over yearNo prior comparable period
2020Year over year0%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -0.1% 2020
Net margin -0.2% 2020
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.19%-0.51%-1.21%-1.91%-2.61%201620192020
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2016Operating margin-1.9%
2019Operating margin-0.2%
2020Operating margin-0.1%
2016Net margin-2.4%
2019Net margin-0.3%
2020Net margin-0.2%
2016Free cash flow marginNot reported
2019Free cash flow marginNot reported
2020Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -426.9K 2020
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.586.2K-1.5M-3.7M-5.8M-7.9M201620192020
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Operating cash flow-7327845
2019Operating cash flow-3251229
2020Operating cash flow-426933

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Free cash flowUnavailable
2019Free cash flowUnavailable
2020Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

38,597.5% 2019
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.41,685%31,264%20,843%10,421%0%201620192020
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2016Liabilities / assets1,292.9%
2019Liabilities / assets38,597.5%
2020Liabilities / assetsNot reported

Current assets to current liabilities

Current assets divided by current liabilities.

0.05× 2019
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.50×0.38×0.25×0.13×0.00×201620192020-12-31
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2016Current assets / current liabilities0.47×
2019Current assets / current liabilities0.05×
2020-12-31Current assets / current liabilitiesNot reported

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
−USD 25.88 million
Exact value

Exact value: -25878675 USD

2016-01-01 – 2016-12-31: -25878675 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.33 million
Exact value

Exact value: -7327845 USD

2016-01-01 – 2016-12-31: -7327845 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2017 2017-01-01 – 2017-12-31
−USD 7.05 million
Exact value

Exact value: -7051572 USD

2017-01-01 – 2017-12-31: -7051572 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.33 million
Exact value

Exact value: -3330096 USD

2017-01-01 – 2017-12-31: -3330096 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2018 2018-01-01 – 2018-12-31
−USD 4.43 million
Exact value

Exact value: -4430399 USD

2018-01-01 – 2018-12-31: -4430399 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.1 million
Exact value

Exact value: -4104884 USD

2018-01-01 – 2018-12-31: -4104884 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2019 2019-01-01 – 2019-12-31
−USD 3.42 million
Exact value

Exact value: -3424811 USD

2019-01-01 – 2019-12-31: -3424811 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.25 million
Exact value

Exact value: -3251229 USD

2019-01-01 – 2019-12-31: -3251229 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2020-01-01 – 2020-12-31
−USD 1.82 million
Exact value

Exact value: -1824690 USD

2020-01-01 – 2020-12-31: -1824690 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 426,933
Exact value

Exact value: -426933 USD

2020-01-01 – 2020-12-31: -426933 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
−USD 1.61 million
Exact value

Exact value: -1610685 USD

2021-01-01 – 2021-12-31: -1610685 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.23 million
Exact value

Exact value: -1228586 USD

2021-01-01 – 2021-12-31: -1228586 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2022-01-01 – 2022-12-31
−USD 1.48 million
Exact value

Exact value: -1484620 USD

2022-01-01 – 2022-12-31: -1484620 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.57 million
Exact value

Exact value: -3566913 USD

2022-01-01 – 2022-12-31: -3566913 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2023-01-01 – 2023-12-31
−USD 8.95 million
Exact value

Exact value: -8948731 USD

2023-01-01 – 2023-12-31: -8948731 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.56 million
Exact value

Exact value: -9555904 USD

2023-01-01 – 2023-12-31: -9555904 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2024-01-01 – 2024-12-31
−USD 4.11 million
Exact value

Exact value: -4112420 USD

2024-01-01 – 2024-12-31: -4112420 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.12 million
Exact value

Exact value: -4124935 USD

2024-01-01 – 2024-12-31: -4124935 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2025-01-01 – 2025-12-31
−USD 3.11 million
Exact value

Exact value: -3108991 USD

2025-01-01 – 2025-12-31: -3108991 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.7 million
Exact value

Exact value: -2700000 USD

2025-01-01 – 2025-12-31: -2700000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

117 filings · 2,655 latest values · 2,655 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001419554, 1419554, BBLG, BBLGW, edgar:1419554

Also known as AFH ACQUISITION X, INC., AFH Acquisition X, Inc., BONE BIOLOGICS CORPORATION, Bone Biologics Corporation, Bone Biologics Corp, Bone Biologics Corporation, Bone Biologics, Corp.